OBJECTIVE: Significant racial disparities are observed in outcomes of women with pregnancy related hypertension (HTN). We evaluated whether text-based remote blood pressure (BP) monitoring could improve this disparity. STUDY DESIGN: This was a planned secondary analysis of a randomized clinical trial that compared the effectiveness of text-based BP monitoring to usual care in-person BP visits for women with pregnancy related HTN in the early postpartum (PP) period. Women were randomized to either two weeks of text-based monitoring using an automated platform and home BP cuff (text) or usual care BP check at their prenatal office 4e6 days following discharge (usual care). Ascertainment of BP, defined as either office visit attendance or at least one BP texted, was compared among black and non-black women. Need for an oral antihypertensive and HTN readmission was compared between groups. Chi square was used to compare categorical variables. Poisson regression with a robust variance assumption was used to test for an interaction between BP ascertainment and race by trial arm to evaluate the impact of text on the disparity between black and non-black BP ascertainment. RESULTS: 206 women participated in the trial (103 per arm). Seventy-three (71%) women in usual care and 68 (66%) in text were black. Non-black women were significantly more likely than black women to present for a BP visit in usual care (70% vs 33%, p<0.001). Text-based monitoring significantly improved BP ascertainment for both black and non-black women compared to usual care (93% vs 33%, p<0.001 and 91% vs 70%, p ¼0.03 respectively). Remote monitoring was able to eliminate the racial disparity observed in BP ascertainment (p¼0.002), with over 90% BP ascertainment in both race groups (p¼0.85) (Figure) . There were no HTN readmissions in the text arm, whereas 4 readmissions were observed in usual care (3 of the 4 in black women). There was no difference in the percent of black women started on BP medication amongst those who texted or attended their office visit (19% vs 21%, p¼0.73 National Mie Hospital, Tsu, Mie, Japan OBJECTIVE: To identify the incidence rates of primary cytomegalovirus (CMV) infection during pregnancy and subsequent congenital CMV infection in Japan by conducting a maternal CMV antibody screening program in a large population of Mie Prefecture, Japan. STUDY DESIGN: We performed a population-based, observational, prospective cohort study. Women in early pregnancy were registered and tested for both CMV IgG and IgM antibodies. For the pregnant women who had positive results for both IgG and IgM antibodies, the IgG avidity index was measured. Those who had negative IgG antibody results were instructed by their obstetricians to take preventive measures against primary infection during pregnancy. Then, the women were retested for both IgG and IgM antibodies at late pregnancy. Primary infections were considered in the following two antibody screening results: one was positive IgG antibody, positive IgM antibody, and low IgG avidity index, and the other was IgG antibody seroconversion at late pregnancy from negative IgG antibody results at early pregnancy. For the pregnant women with primary infection, CMV DNA tests were performed for congenital infection. RESULTS: From September 2013 to March 2017, 19,435 pregnant women were registered in 24 centers in Mie Prefecture, Japan. Of 1,037 pregnant women with both positive IgG and IgM results, 115 showed a low IgG avidity index and were considered as having a primary infection. Of 6,636 pregnant women with negative IgG results at early pregnancy, only 4,082 were retested for IgG and IgM antibodies at late pregnancy, as 2,554 women had missing data. Of the 4,082 pregnant women with negative IgG results at early pregnancy, 31 showed IgG antibody seroconversion at late pregnancy and were considered as having a primary infection. Twenty-three women delivered a fetus with a congenital infection; 8 of 115 women had low IgG avidity index, and 15 of 31 women had IgG seroconversion. The observed incidence rates of primary and subsequent congenital infections were 0.75% and 0.12%, respectively (115 + 31 primary infection and 8 + 15 congenital infection, respectively). The estimated rates that the missing data were corrected were 0.85% and 0.16%, respectively (115 + 50 primary infection and 8 + 24 congenital infection, respectively). CONCLUSION: The incidence rates of primary CMV infection during pregnancy and subsequent congenital CMV infection in Japan were estimated to be 0.85% and 0.16%, respectively.
